CN Menu
Press Release
Evergreen Therapeutics and HwaGen Pharmaceutical Sign In-depth Cooperation Agreement to Build a New Highland of Medical Innovation
Source:Evergreen Date: May,2022 Views: 526

On May 28, 2022, Dr. Tom Du, Chairman of Evergreen Therapeutics and Dr. Charles Lee, CMO of Evergreen Therapeutics, attended the "First Academic Forum of HwaGen medical thinks markets 2022" sponsored by HwaGen Pharma. The conference was strongly supported by the local government, industry associations, and research institutions.


Dr. Tom Du delivers his speech during the “First Academic Forum” sponsored by HwaGen Pharma.